CAS: 36805-97-7; 1,1-Di-Tert-Butoxy-N,N-Dimethylmethanamine

该化合物是一种异丁氧代代金化合物,其结构具有有机合成和催化用途,结构上有两个异丁氧基组和二甲基氨基杂质,具有不动阻力和核生殖性,在选择性反应中具有优势.三丁氧组增强稳定性和影响反应,使其在复杂的转化中作为捆绑或中间体发挥作用.这种复合体因其参与金属协调的能力和作为专门试剂的前体而特别受重视.在各种条件下,其受控制的再活性和稳定性适合于精细化学合成,需要精确的功能类操纵.

结构式图片

相似化合物

18503-89-4 1188-33-6 1188-33-6

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号865-47-4 叔丁醇钾 | CAS号2013-91-4 [(dimethylamino... | CAS号3218-35-7 N,N,N',N'-Tetra... | CAS号4637-24-5 N,N-二甲基甲酰胺二甲基缩醛 | CAS号75-65-0 叔丁醇 | CAS号2214-82-6 bis(dimethylami... | CAS号5815-08-7 叔丁氧基双(二甲胺基)甲烷 | CAS号43052-39-7 戊二酸二叔丁酯 | CAS号491-36-1 4-Quinazolinone | CAS号1332493-38-5 4-(1,1-dimethyl... | CAS号113260-96-1 3-(1,1-dimethyl... | CAS号941294-58-2 6-溴烟酸叔丁酯 | CAS号19756-72-0 4-硝基苯甲酸叔丁酯 | CAS号23408-05-1 2-羟基苯甲酸叔丁酯 | CAS号85144-30-5 tert-butyl 2-(t... | CAS号295349-62-1 2-氯异烟酸叔丁酯 | CAS号18605-26-0 N-Cbz-beta-丙氨酸叔丁酯

合成工艺路线路线简述

  • 合成目标产物 N,N-Dimethylformamide Di-Tert-Butyl Acetal 主要起始原料 Potassium Tert-Butoxide And [(Dimethylamino)Methylene]Dimethylammonium Methyl Sulphate
  • (文献来源)合成步骤主要原料 Potassium Tert-Butoxide 和 [(Dimethylamino)Methylene]Dimethylammonium Methyl Sulphate
Bredereck 试剂置于五羰基铁体系中,化学反应 21.0H,反应生成 N,N-二甲基甲酰胺二叔丁基缩醛,Alkaline Earth Salt Of/the/ Methylsulfuric Acid
参考文献:Daub,Joerg; Hasenhuendl,Adelheid; Krenkler,Karl P.,Liebigs Annalen Der Chemie,1980,# 7,P. 997-1015
标题:Daub,Joerg; Hasenhuendl,Adelheid; Krenkler,Karl P.,Liebigs Annalen Der Chemie,1980,# 7,P. 997-1015

海关参考信息

专利信息


专利号:US-11274081-B2
优先权日:2016-05-30
标 题:Process for the synthesis of ivacaftor
发明人:REDDY DUMBALA SRINIVASA; KULKARNI AMOL ARVIND; NATARAJAN VASUDEVAN; SHARMA MRITYUNJAY KESHAVPRASAD
权利人:COUNCIL SCIENT IND RES
摘要:The present disclosed an improved process for the synthesis of ivacaftor starting from indole acetic acid ester which can be performed in batch as well as continuous flow synthesis. The present invention further disclosed to a continuous process for the synthesis of compound of formula (II) or formula (III) from compound of formula (I) in continuous flow reactor.

专利号:US-2006287520-A1
优先权日:2005-05-16
标 题 :Synthesis of salinosporamide A and analogues thereof
发明人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
权利人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
摘要:A novel synthesis of salinosporamide A is provided. Salinospoamide A as well as structurally related natural products, omuralide and lactacystin, have been shown to be proteasome inhibitors. Therefore, these compounds as well as analogues of these natural products may be useful in the treatment of proliferative diseases such as cancer, autoimmune diseases, diabetic retinopathy, etc. The invention provides for the synthesis of salinosporamide A as well as analogs thereof using a convenient point for derivatization of the bicyclic core. Pharmaceutical compositions and method of using the inventive compounds are also provided.

专利号:US-6225329-B1
优先权日:1998-03-12
标 题 :Modulators of protein tyrosine phosphatases (PTPases)
发明人:RICHTER LUTZ STEFAN; ANDERSEN HENRIK SUNE; VAGNER JOSEF; JEPPESEN CLAUS BEKKER; MOELLER NIELS PETER HUNDAHL; BRANNER SVEN; SU JING; BAKIR FARID; JUDGE LUKE MILBURN
权利人:NOVO NORDISK AS
摘要:The present invention provides novel compounds of Formula 1, compositions containing these compounds, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like, n wherein A, R 1 , R 2 , R 3 , R 4 , R 16 and R 17 are as defined in the specification. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.

专利号:WO-9946236-A1
优先权日:1998-03-12
标题 :Modulators of protein tyrosine phosphatases (ptpases)
发明人:RICHTER LUTZ STEFAN; ANDERSEN HENRIK SUNE; VAGNER JOSEF; JEPPESEN CLAUS BEKKER; MOELLER NIELS PETER HUNDAHL; BRANNER SVEN; SU JING; BAKIR FARID; JUDGE LUKE MILBURN
权利人:NOVO NORDISK AS; ONTOGEN CORP
摘要:The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPases) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.

专利号:EP-1062199-A1
优先权日:1998-03-12
标题 :Modulators of protein tyrosine phosphatases (ptpases)
发明人:RICHTER LUTZ STEFAN; ANDERSEN HENRIK SUNE; VAGNER JOSEF; JEPPESEN CLAUS BEKKER; MOLLER NIELS PETER HUNDAHL; BRANNER SVEN; SU JING; BAKIR FARID; JUDGE LUKE MILBURN
权利人:NOVO NORDISK AS; ONTOGEN CORP
摘要:The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPases) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.

专利号:US-2004152897-A1
优先权日:2002-09-13
标 题 :Synthesis of indolizines
发明人:SUN LIJUN; KOYA KEIZO; XIA ZHI-QIANG; PRZEWLOKA TERESA; ZHANG SHIJIE; ONO MITSUNORI
权利人:SYNTA PHARMACEUTICALS CORP
摘要:Disclosed are methods of preparing substituted indolizines represented by the following formula: n n n comprising reacting a substrate represented by the following formula: n n n with either the cyclization reagent of the following formula: n n n or, a reagent prepared by reacting the compound represented the formula below with an alkylating agent: n n n The variables in the above formulas are defined herein.
苏州汉德创宏生化科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.handesciences.com
电话: 0086-512-88865304👤
📞苏州汉德创宏生化科技有限公司 ⚠️参考联系方式

销售电话:0086-512-88865304
邮箱:dma@handesciences.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
常州市力仁医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.lirenchem.com
电话:0519-85859058,13915836899👤
📞 常州市力仁医药科技有限公司⚠️参考联系方式

电话: 0519-85859058,13915836899
邮件:sales@lirenchem.com
网址: http://www.lirenchem.com
地址:江苏省常州市天宁区东仓桥弄1号
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

江苏省常州市天宁区东仓桥弄1号
⚠️ 未注册 · 未认证企业
注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: E Mohacsi, Et Al. Synthesis And Pharmacology Of Metabolically Stable Tert-Butyl Ethers Of Morphine And Levorphanol. J Med Chem. 1982 Oct;25(10):1264-6.
[参考文献]: N C Jain, Et Al. Simultaneous Determination Of Cocaine And Benzoyl Ecgonine In Urine By Gas Chromatography With On-Column Alkylation. J Forensic Sci. 1977 Jan;22(1):7-16.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知